L&C Bio Co., Ltd (290650.KQ) KOE

51,050.00

+2100(+4.29%)

Updated at September 09 02:02PM

Currency In KRW

Valuation

Market Cap546.71B
Enterprise Value652.32B
P/E Ratio9.32
PEG Ratio-0.89
Price/Sales Ratio16.54
Price/Book Ratio4.09
Enterprise/Revenue18.01
Enterprise/EBITDA8.5

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin1.64
Operating Margin-0.01

Management Effectiveness

Return On Assets0.29
Return On Equity0.58

Income Statement

Revenue72.09B
Revenue/Share3,348.95
Gross Profit35.73B
EBITDA147.77B
Net Income141.06B
Diluted EPS5,727.24

Balance Sheet

Total Cash14.1B
Total Cash/Share621.52
Total Debt119.56B
Total Debt/Equity0.42
Current Ratio0.8
Book Value Per Share12,930.99

Price History

52-Week Change199.41
52-Week High53,900
52-Week Low15,000
Moving Average 50 Days31,976
Moving Average 200 Days25,045.45

Statistics

Average Volume562,315
Shares Outstanding24.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate50
Trailing Annual Dividend Yield0.1
Payout Ratio0.02
Last Split Factor3:1
Last Split DateOctober 12, 2020